Ratings by H.C. Wainwright (Michael G. King, Jr.)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/8/2024 | Agenus Inc. | AGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | Vincerx Pharma | VINC | Maintain | Buy (N/A) |
|
Details | ||
| 1/19/2022 | Kintara Therapeutics, Inc | KTRA | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2022 | Vincerx Pharma | VINC | New Coverage | Buy (N/A) |
7.90 (0.10) |
-98.73% | Details | |
| 1/10/2022 | Xilio Therapeutics Inc | XLO | New Coverage | Buy (N/A) |
14.32 (9.05) |
-36.8% | Details | |
| 12/23/2021 | Elevation Oncology | ELEV | New Coverage | Buy (N/A) |
4.90 (0.37) |
-92.45% | Details | |
| 12/16/2021 | Agenus Inc. | AGEN | New Coverage | Buy (N/A) |
3.24 (3.03) |
-6.48% | Details | |
| 11/5/2021 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2021 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2021 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2021 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 6/11/2021 | Intellia Therapeutics | NTLA | New Coverage | Buy (N/A) |
83.15 (16.68) |
-79.94% | Details |
